**INTRODUCTION:** Acellular Dermal Matrix (ADM) for abdominal wall reconstruction (AWR) results in less infectious wound complications but similar hernia recurrence compared to non-biologic mesh. However, it is not clear the long-term recurrence rates using ADM for AWR. Very few data are available on this topic as most studies have insufficient long-term follow-up. We hypothesized that AWR using ADM shows durable long-term (\>36 months) outcome concerning hernia recurrence rate.

**MATERIALS AND METHODS:** This study included 191 consecutive patients, who underwent AWR with ADM for repair of complex hernia and/or oncologic resection at a major US cancer center with a minimum follow-up of 36 months. The average is 58.2 ± 12.1 years with a mean follow-up of 55.6 months (range 36--104 months).

**RESULTS:** Approximately 80% of patients had AWR with component separation and 8% had a bridged repair. The most frequently used mesh was porcine (Strattice, 56.5%), followed by bovine (Surgimend, 31.1%) and human (Alloderm, 10.9%). There were 31 (16.2%) hernia recurrences with a surgical site occurrence rate of 25.1%. Among these patients, 13% had hernia recurrence within 3 years, while 16.7% at 5 years. BMI, bridged repair and Alloderm are associated with higher hernia recurrence rate (respectively, HR=1.9, p=0.09; HR=10.1, p\<0.001; HR=2.52, p=0.044). When bridged repairs and Alloderm cases are excluded, hernia recurrence rate drops to 8.2% within 3 years and 10.7% at 5 years follow-up.

**CONCLUSIONS:** The use of ADM for AWR is associated to a low hernia recurrence rate at long-term follow-up. These outcomes can be optimized avoiding bridged repairs and Alloderm meshes.
